GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PharMerica Corp (NYSE:PMC) » Definitions » Days Sales Outstanding

PharMerica (PharMerica) Days Sales Outstanding : 38.01 (As of Sep. 2017)


View and export this data going back to 2007. Start your Free Trial

What is PharMerica Days Sales Outstanding?

PharMerica's average Accounts Receivable for the three months ended in Sep. 2017 was $248 Mil. PharMerica's Revenue for the three months ended in Sep. 2017 was $595 Mil. Hence, PharMerica's Days Sales Outstanding for the three months ended in Sep. 2017 was 38.01.

The historical rank and industry rank for PharMerica's Days Sales Outstanding or its related term are showing as below:

PMC's Days Sales Outstanding is not ranked *
in the Medical Distribution industry.
Industry Median: 76.76
* Ranked among companies with meaningful Days Sales Outstanding only.

PharMerica's Days Sales Outstanding increased from Sep. 2016 (37.69) to Sep. 2017 (38.01).


PharMerica Days Sales Outstanding Historical Data

The historical data trend for PharMerica's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharMerica Days Sales Outstanding Chart

PharMerica Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 43.56 41.92 37.95 35.62 38.04

PharMerica Quarterly Data
Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.69 38.49 38.90 38.10 38.01

Competitive Comparison of PharMerica's Days Sales Outstanding

For the Medical Distribution subindustry, PharMerica's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PharMerica's Days Sales Outstanding Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, PharMerica's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where PharMerica's Days Sales Outstanding falls into.



PharMerica Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

PharMerica's Days Sales Outstanding for the fiscal year that ended in Dec. 2016 is calculated as

Days Sales Outstanding (A: Dec. 2016 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2015 ) + Accounts Receivable (A: Dec. 2016 )) / count ) / Revenue (A: Dec. 2016 )*Days in Period
=( (200.5 + 235.4) / 2 ) / 2091.1*365
=217.95 / 2091.1*365
=38.04

PharMerica's Days Sales Outstanding for the quarter that ended in Sep. 2017 is calculated as:

Days Sales Outstanding (Q: Sep. 2017 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Jun. 2017 ) + Accounts Receivable (A: Sep. 2017 )) / count ) / Revenue (A: Sep. 2017 )*Days in Period
=( (246.6 + 249.2) / 2 ) / 595.1*365 / 4
=247.9 / 595.1*365 / 4
=38.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PharMerica  (NYSE:PMC) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


PharMerica Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of PharMerica's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


PharMerica (PharMerica) Business Description

Traded in Other Exchanges
N/A
Address
PharMerica provides pharmacy services to institutional healthcare providers in the United States. The firm has three operating segments: institutional pharmacy, specialty infusion services, and specialty oncology pharmacy. The institutional pharmacy business provides pharmacy products and services to skilled nursing facilities, nursing centers, assisted living facilities, hospitals, and long-term care settings. It purchases, repackages, and dispenses pharmaceuticals and provides on-call pharmacist services to these customers. The specialty infusions segment delivers specialty infusion therapy to patients outside of hospitals and nursing homes. The specialty oncology pharmacy dispenses oncology drugs and provides care management services to patients, oncology practices, and hospitals.
Executives
Marjorie W Dorr director ANTHEM INC., 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Gregory S Weishar director, officer: Chief Executive Officer ONE CVS DR, WOONSOCKET RI 02895
Geoffrey G Meyers director 333 NORTH SUMMIT ST, 16TH FLOOR, TOLEDO OH 43604
Robert E. Dries officer: CFO 701 COOL SPRINGS BOULEVARD FRANKLIN TN 37067
Patrick G Lepore director 17-17 ROUTE 208 N, FAIRLAWN NJ 07410
Thomas A Caneris officer: SVP, GC and Secretary 1901 CAMPUS PLACE, LOUISVILLE KY 40299
Froesel David W Jr officer: Executive VP, CFO & Treasurer
Thomas P Gerrity director
Mac Mahon Thomas P director
Daniel Newman Mendelson director COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR, SUITE 900, BETHESDA MD 20817
Edward L Kuntz director
R David Yost director 1300 MORRIS DRIVE, SUITE 100, CHESTERBROOK PA 19087
Paul J Diaz director 680 SOUTH FOURTH STREET, LOUISVILLE KY 40202

PharMerica (PharMerica) Headlines

From GuruFocus

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 11-04-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 81,000 Shares

By GuruFocus Research GuruFocus Editor 08-13-2010

Weekly CFO Buys Highlight: PMC, ZBB

By gurujk gurujk 06-25-2012

PharMerica Corp. Reports Operating Results (10-Q)

By gurufocus 10qk 08-05-2010

PharMerica Corp. (PMC) CEO Gregory S Weishar buys 25,000 Shares

By GuruFocus Research GuruFocus Editor 11-16-2009